Biotech Archives - BioPharmaJournal

Cronos Group Inc (NASDAQ: CRON) and Ginkgo Bioworks Holdings Inc (NYSE:...

Gavins Felicity - June 27, 2022 0

Caribou Biosciences Inc (NASDAQ: CRBU) Unveils More Positive Initial Data Emanating...

Gavins Felicity - June 24, 2022 0

MEI Pharma Inc (NASDAQ: MEIP) and Kyowa Kirin Announce Clinical Data...

Gavins Felicity - June 23, 2022 0

Amarin Corporation plc (NASDAQ: AMRN) Applauds VAZKEPA’S Recommendation from United Kingdom’s...

Gavins Felicity - June 22, 2022 0

Fulcrum Therapeutics, Inc (NASDAQ: FULC) Says the Unveiled Proof-Of-Concept For FTX-6058...

Gavins Felicity - June 21, 2022 0

Cogent Biosciences Inc (NASDAQ: COGT) says The Ongoing Phase 2 APEX...

Gavins Felicity - June 20, 2022 0

Bristol-Myers Squibb Co (NYSE: BMY) Announces Plan to Purchase Turning Point...

Gavins Felicity - June 17, 2022 0

The U.S FDA Announces That Novavax, Inc. (NASDAQ: NVAX) is Effective...

Gavins Felicity - June 16, 2022 0

The FDA Has Increased The Review Time For Amylyx Pharmaceuticals Inc’s...

Gavins Felicity - June 15, 2022 0

Curis, Inc. (NASDAQ: CRIS) Will Present Data on Its TakeAim Leukaemia...

Gavins Felicity - June 14, 2022 0

12 3...153 Page 1 of 153

CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...

Gavins Felicity - July 5, 2022 0

CymaBay Therapeutics Inc (NASDAQ: CBAY) has announced the presentation of promising seladelpar findings in primary biliary cholangitis (PBC) patients at The International Liver Congress...

Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA

July 4, 2022

Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...

July 1, 2022

Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...

June 30, 2022

Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes...

June 30, 2022

Biotech

Recent Post